Scotts Miracle-Gro Company (The) Common Stock (NY:SMG)

48.73 -0.30 (-0.60%)

Delayed Quote Updated: 11:59 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scotts Miracle-Gro Company (The) Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

26 27 Next >

Cannabis Stock Movers For March 22, 2023 ↗

March 22, 2023

Via Benzinga

The Scotts Miracle-Gro Foundation and KidsGardening Announce the 2023 GroMoreGood Grassroots Grantees

March 20, 2023

Program connects children to the benefits of gardening and greenspaces

From Scotts Miracle-Gro Company (The)

Via GlobeNewswire

Cannabis Category Performance Comparisons: An Update ↗

March 19, 2023

Here is a summary of how each of the 5 categories in the cannabis sector has performed month-to-date, in descending order, and year-to-date. The picture isn't pretty.

Via Talk Markets

Wall Street's Most Accurate Analysts Say Buy These 3 Materials Stocks Delivering High-Dividend Yields ↗

March 15, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Ancillary Cannabis Index Up 14.5% YTD ↗

March 04, 2023

The Ancillary Cannabis Stocks Index consists of 7 companies providing goods and/or services to American cannabis multi-state operators (MSOs) and Canadian licensed producers (LPs).

Via Talk Markets

Scotts Miracle-Gro (SMG) Q1 2023 Earnings Call Transcript ↗

February 01, 2023

SMG earnings call for the period ending December 31, 2022.

Via The Motley Fool

All 5 Cannabis Categories Down Last Week; Only 1 Is UP YTD ↗

March 12, 2023

The 5 categories in the cannabis sector perform quite differently from each other. Only 1 is up YTD.

Via Talk Markets

Cannabis Stock Movers For March 9, 2023 ↗

March 09, 2023

Via Benzinga

ScottsMiracle-Gro to hold Fireside Chat with UBS

March 09, 2023

From Scotts Miracle-Gro Company (The)

Via GlobeNewswire

Cannabis Stock Gainers And Losers From March 6, 2023 ↗

March 06, 2023

Via Benzinga

Riv Capital Stock Trading Higher On Stagnating Q3 FY23 Revenue And CEO Departing ↗

March 01, 2023

RIV Capital Inc. (OTCPK:CNPOF) (CSE:RIV) released its financial results for the three months ended December 31, 2022, revealing net revenue of $1.9 million, consistent with the previous quarter (the...

Via Benzinga

A Preview Of The Scotts Miracle Gro's Earnings ↗

January 31, 2023

Via Benzinga

Riv Capital Settles With JW Asset Management, Repurchases Almost 20% Of Its Shares ↗

February 24, 2023

RIV Capital Inc. (OTCPK:CNPOF) (CSE:RIV) has entered into a settlement agreement that has resulted in JW Asset Management, LLC ("JWAM") consenting to the dismissal of its application related to the...

Via Benzinga

Bearish Sentiment Across The Cannabis Space - Check Full Movers For February 21, 2023 ↗

February 21, 2023

Via Benzinga

Marijuana Stock Movers For February 16, 2023 ↗

February 16, 2023

Via Benzinga

ScottsMiracle-Gro to Present at Raymond James & Associates 44th Annual Institutional Investors Conference

February 16, 2023

From Scotts Miracle-Gro Company (The)

Via GlobeNewswire

Cannabis Stock Movers For February 15, 2023 ↗

February 15, 2023

Via Benzinga

Marijuana Stock Movers For February 13, 2023 ↗

February 13, 2023

Via Benzinga

ScottsMiracle-Gro to hold Fireside Chat with Wells Fargo

February 09, 2023

From Scotts Miracle-Gro Company (The)

Via GlobeNewswire

AgTech Firm Looking to Acquire Rapidly Growing Foods Company Amid Drive Toward Sustainable Produce ↗

February 09, 2023

Click here to download the latest research report on AgriFORCE.

Via Benzinga

Miracle-Gro's Subsidiaries Sue TerrAscend, JW Asset Mgt & Jason Wild For Trying To Ruin Its $175M Investment ↗

February 08, 2023

The Hawthorne Gardening Company and Hawthorne Collective, subsidiaries of the Scotts Miracle-Gro Co (NYSE: SMG), sued JW Asset Management, LLC, TerrAscend Corp (OTCQX: TRSSF

Via Benzinga

Cannabis Stock Movers For February 2, 2023 ↗

February 02, 2023

Via Benzinga

Cannabis Stock Movers For February 1, 2023 ↗

February 01, 2023

Via Benzinga

Scotts Miracle-Gro Hits Bottom, Reversal In Play

February 01, 2023

Scotts Miracle-Gro hit bottom and has a reversal in play that could take it higher, how much higher is the question for investors.

Via MarketBeat

Topics Cannabis

5 Most Expensive Materials Stocks You Should Worry About ↗

February 01, 2023

The most overbought stocks in the materials sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

ScottsMiracle-Gro Q1 Net Sales Decline 7% YoY, What About Adjusted EBITDA? ↗

February 01, 2023

The Scotts Miracle-Gro Company (NYSE: SMG) released results for its fiscal first quarter ended December 31, 2022, revealing net sales of $526.6 million, a 7% decrease compared to $566 million in the Q1...

Via Benzinga

ScottsMiracle-Gro Reports First Quarter Results

February 01, 2023

From Scotts Miracle-Gro Company (The)

Via GlobeNewswire

Bullish Tuesday For Marijuana Stocks - iAnthus Capital Hldgs, TerrAscend Among Top Gainers ↗

January 31, 2023

Via Benzinga

Stocks With 'AI' In the Name Are Soaring: Could It Be The Next Crypto-, Cannabis-Style Stock Naming Craze? ↗

January 31, 2023

For the past few years, many companies have pivoted their visions to include a new, trending topic. At one point it was crypto, blockchain or NFTs and before that it was cannabis. Now, it might be...

Via Benzinga

Earnings Scheduled For February 1, 2023 ↗

February 01, 2023

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.